About Recursion
Founded in 2013 in Salt Lake City, Utah, Recursion is a clinical-stage company leading at the intersection of tech and bio by decoding biology to industrialise drug discovery. From the start, Recursion’s vision has been to leverage technology to discover and develop better medicines faster.
Collaborating with global leaders
Recursion has secured some of the largest discovery collaborations in the industry with leading biopharma companies to pursue complex areas of biology, such as neuroscience with Roche/Genentech and precision oncology with Bayer. It has also secured technology partnerships with companies like NVIDIA and Tempus, focusing on accelerating the development of more powerful AI models.
How London & Partners helped
Recursion will continue pioneering advances in medicine at the intersection of technology and biology, building on London’s reputation as a hub for cutting-edge research and innovation. It’s also eager to harness the power of London’s biotech ecosystem to collaborate with leaders in the space, across both technology and biopharma industries, as well as academic institutions.
The outcome
Recursion is excited to hire new “Recursionauts” who will help advance its mission of decoding biology to radically improve lives.